Key result
Cardio-oncology review highlights complex drug interactions, novel cardiotoxicity detection, and emerging reverse cardio-oncology.
Why the study?
Therapy development for cancer and cardiovascular disease to prolong lifespan has made the relationship between these two conditions increasingly complex.
Design
Review
Authors
Loading...
Highlights the need for multidisciplinary awareness of bidirectional cardiovascular-cancer risks; leaves open the clinical utility of.
The field of cardio-oncology is evolving to include complex drug interactions, novel biomarkers and imaging for cardiotoxicity, and the concept of CVD-related cancer risk.
Li et al. (2023) conducted a review in Cancer and cardiovascular disease. The evolving field of cardio-oncology encompasses complex drug interactions, novel methods for detecting cardiotoxicity, and the emerging concept of reverse cardio-oncology.